Skip to content

Clinical trials

Completed Observational Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Observational Status: Completed Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20053
20062
20071
20083
20092
20104
20114
20125
20136
20145
20154
20164
201713
20184
20193
202010
20215
20226
20239
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Assiut University4
Celgene4
National Heart, Lung, and Blood Institute (NHLBI)4
Columbia University3
Weill Medical College of Cornell University3
Centre Hospitalier Universitaire de Nice2
Chung-Ang University Hospital2
Hospices Civils de Lyon2
Kingston University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial104
Idiopathic Pulmonary Fibrosis21
Pulmonary Disease, Chronic Obstructive15
Pulmonary Fibrosis10
Asthma7
Lung Neoplasms7
Heart Failure6
Hypertension, Pulmonary6
Lung Diseases6
Sarcoidosis6

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.